Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $309.4700 (-1.36%) ($306.9300 - $315.9999) on Tue. Jun. 10, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.41% (three month average) | RSI | 72 | Latest Price | $309.4700(-1.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 2.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(38%) XBI(37%) QQQ(31%) SPY(30%) XLK(28%) | Factors Impacting REGN price | REGN will decline at least -1.205% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.205% (StdDev 2.41%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $310.97(-0.48%) | 10 Day Moving Average | $309.42(0.02%) | 20 Day Moving Average | $302.46(2.32%) | To recent high | -7.1% | To recent low | 10.8% | Market Cap | $32.813b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |